BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 1198469)

  • 1. Proceedings: Inhibition of human platelet aggregation by the proteolytic effect of streptokinase (SK). Role of the factor VIII related antigen.
    Castillo R; Maragall S; Guisasola JA; Casals F; Ruiz C; Ordinas A
    Thromb Diath Haemorrh; 1975 Nov; 34(2):574. PubMed ID: 1198469
    [No Abstract]   [Full Text] [Related]  

  • 2. Inhibition of human platelet aggregation by the proteolytic effect of streptokinase. Role of the human factor-VIII-related protein.
    Castillo R; Maragall S; Guisasola JA; Casals F; Profitós J; Ordinas A
    Haemostasis; 1976; 5(5):306-17. PubMed ID: 1087912
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Functional significance of intra-platelet factor VIII-related antigen].
    Grignani G; Piovella F; Malamani GD; Cattaneo G
    Boll Soc Ital Biol Sper; 1977 Sep; 53(17):1489-94. PubMed ID: 75736
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparative effects of recombinant staphylokinase and streptokinase on platelet aggregation.
    Abdelouahed M; Hatmi M; Helft G; Emadi S; Elalamy I; Samama MM
    Thromb Haemost; 1997 May; 77(5):815-7. PubMed ID: 9184383
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Time course of platelet aggregation during thrombolytic treatment of massive pulmonary embolism.
    Mühl D; Füredi R; Gecse K; Ghosh S; Falusi B; Bogár L; Roth E; Lantos J
    Blood Coagul Fibrinolysis; 2007 Oct; 18(7):661-7. PubMed ID: 17890954
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proceedings: Effects of bovine factor VIII-related protein on human platelets and isolated human platelet membranes.
    Solum NO
    Thromb Diath Haemorrh; 1975 Nov; 34(2):594-5. PubMed ID: 1239097
    [No Abstract]   [Full Text] [Related]  

  • 7. Characterization of a form of bovine factor VIII which does not aggregate human platelets.
    Kirby EP
    Thromb Haemost; 1981 Aug; 46(2):479-84. PubMed ID: 6795738
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Platelet hyperaggregability in the nephrotic syndrome which is not dependent on arachidonic acid metabolism or on plasma albumin concentration.
    Bennett A; Cameron JS
    Clin Nephrol; 1987 Apr; 27(4):182-8. PubMed ID: 3107859
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of insulin treatment in streptozocin-induced diabetic rats on in vitro platelet function and plasma von Willebrand factor activity and factor VIII-related antigen.
    Winocour PD; Lopes-Virella M; Laimins M; Colwell JA
    J Lab Clin Med; 1985 Sep; 106(3):319-25. PubMed ID: 3928783
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [IIB-type Willebrand disease (a case of increased ristomycin-induced aggregation)].
    Boda Z; Hársfalvi J; Rák K
    Orv Hetil; 1985 Aug; 126(32):1957-60. PubMed ID: 2993980
    [No Abstract]   [Full Text] [Related]  

  • 11. [Factor VIII preparations of varying purity-examination of physico-chemical parameters (author's transl)].
    Vukovich T; Koller E; Doleschel W; Mayr WR
    Wien Klin Wochenschr; 1980; 92(11):385-91. PubMed ID: 6775418
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of P2Y(1) and P2Y(12) receptor antagonists on platelet aggregation induced by different agonists in human whole blood.
    Storey RF; Newby LJ; Heptinstall S
    Platelets; 2001 Nov; 12(7):443-7. PubMed ID: 11674863
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human anti-streptokinase antibodies induce platelet aggregation in an Fc receptor (CD32) dependent manner.
    Lebrazi J; Helft G; Abdelouahed M; Elalamy I; Mirshahi M; Samama MM; Lecompte T
    Thromb Haemost; 1995 Sep; 74(3):938-42. PubMed ID: 8571325
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The behavior of factor VIII associated antigen, platelet retention and thrombocyte aggregation in patients with vascular diseases].
    Scharrer I; Pander U; Kirchmaier C; Rüfer A; Maas C
    Verh Dtsch Ges Inn Med; 1978; (84):1373-5. PubMed ID: 741969
    [No Abstract]   [Full Text] [Related]  

  • 15. Proceedings: Inhibition of bovine factor VIII and ristocetin plus human factor VIII induced platelet agglutination by small peptides.
    Macfarlane DE
    Thromb Diath Haemorrh; 1975 Nov; 34(2):582-3. PubMed ID: 1239092
    [No Abstract]   [Full Text] [Related]  

  • 16. Interactions of purified rat factor VIII/von Willebrand factor with rat and human platelets--effect of albumin and ristocetin.
    Dejana E; Furlan M; Barbieri B; Donati MB; Beck EA
    Thromb Haemost; 1984 Aug; 52(1):57-9. PubMed ID: 6437011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proceedings: Interaction of fibrinogen and factor VIII with human platelets.
    Schneider-Trip M; Wanders R; ten Cate JW; Jenkins C
    Thromb Diath Haemorrh; 1975 Nov; 34(2):581. PubMed ID: 1198486
    [No Abstract]   [Full Text] [Related]  

  • 18. [Effects of smoking on platelet aggregation and plasma levels of factor VIII relative antigen].
    Xia JR
    Zhonghua Yi Xue Za Zhi; 1987 Apr; 67(4):187-9, 12. PubMed ID: 3115510
    [No Abstract]   [Full Text] [Related]  

  • 19. Time course of changes in in vitro platelet function and plasma von willebrand factor activity (VIIIR:WF) and factor VIII-related antigen (VIIIR:Ag) in the diabetic rat.
    Winocour PD; Lopes-Virella M; Laimins M; Colwell JA
    J Lab Clin Med; 1983 Nov; 102(5):795-804. PubMed ID: 6415193
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coagulation assays and platelet aggregation patterns in human, baboon, and canine blood.
    Feingold HM; Pivacek LE; Melaragno AJ; Valeri CR
    Am J Vet Res; 1986 Oct; 47(10):2197-9. PubMed ID: 3096173
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.